Cambridge Investment Research Advisors, Inc. Cara Therapeutics, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$8.88 - $12.77 $2,495 - $3,588	281 Added 1.43%	19,956 $214,000
Q3 2022 Oct 17, 2022	BUY	$8.24 - $12.56 $2,109 - $3,215	256 Added 1.32%	19,675 $184,000
Q2 2022 Jul 13, 2022	SELL	$7.45 - $13.84 $5,311 - $9,867	-713 Reduced 3.54%	19,419 $177,000
Q1 2022 May 12, 2022	BUY	$9.94 - $12.65 $24,671 - $31,397	2,482 Added 14.06%	20,132 $244,000
Q4 2021 Feb 03, 2022	BUY	$11.99 - $18.14 $3,009 - $4,553	251 Added 1.44%	17,650 $214,000
Q3 2021 Nov 02, 2021	BUY	$11.55 - $16.06 $38,600 - $53,672	3,342 Added 23.77%	17,399 $268,000
Q2 2021 Aug 10, 2021	BUY	$12.38 - $29.19 $8,975 - $21,162	725 Added 5.44%	14,057 $200,000
Q1 2021 May 07, 2021	BUY	$15.07 - $21.71 $43,944 - $63,306	2,916 Added 28.0%	13,332 $289,000
Q4 2020 Feb 04, 2021	BUY	$12.72 - $16.16 $132,491 - $168,322	10,416 New	10,416 $157,000
Q3 2020 Oct 29, 2020	SELL	$12.34 - $17.92 $124,288 - $180,490	-10,072 Closed	0 $0
Q2 2020 Jul 27, 2020	SELL	$12.39 - $17.33 $2,478 - $3,465	-200 Reduced 1.95%	10,072 $172,000
Q1 2020 May 08, 2020	SELL	$9.12 - $17.78 $17,984 - $35,062	-1,972 Reduced 16.11%	10,272 $135,000
Q4 2019 Feb 04, 2020	SELL	$16.11 - $25.98 $11,180 - $18,030	-694 Reduced 5.36%	12,244 $197,000
Q3 2019 Nov 06, 2019	SELL	$18.28 - $26.91 $127,027 - $186,997	-6,949 Reduced 34.94%	12,938 $236,000
Q2 2019 Aug 15, 2019	SELL	$17.68 - $21.57 $150,845 - $184,035	-8,532 Reduced 30.02%	19,887 $0
Q1 2019 May 08, 2019	SELL	$14.41 - $19.64 $2,449 - $3,338	-170 Reduced 0.59%	28,419 $0
Q4 2018 Feb 05, 2019	BUY	$12.45 - $23.47 $26,605 - $50,155	2,137 Added 8.08%	28,589 $371,000
Q3 2018 Nov 02, 2018	BUY	$17.57 - $23.95 $99,200 - $135,221	5,646 Added 27.14%	26,452 $0
Q2 2018 Aug 10, 2018	BUY	$11.6 - $19.27 $5,220 - $8,671	450 Added 2.21%	20,806 $0
Q1 2018 May 09, 2018	BUY	$11.77 - $16.08 $10,122 - $13,828	860 Added 4.41%	20,356 $0
Q4 2017 Feb 22, 2018	SELL	$11.86 - $14.08 $16,604 - $19,712	-1,400 Reduced 6.7%	19,496 $0
Q3 2017 Nov 07, 2017	BUY	$12.6 - $16.34 $27,543 - $35,719	2,186 Added 11.68%	20,896 $286,000
Q2 2017 Aug 08, 2017	BUY	N/A	18,710	18,710 $288,000

Others Institutions Holding CARA

# of Institutions

Shares Held

12.8M

Call Options Held

Put Options Held

Vanguard Group Inc Valley Forge, PA

2.25M
Shares

$10.3 Million
0.0% of portfolio
Chescapmanager LLC Baltimore, MD

1.7M
Shares

$7.83 Million
0.06% of portfolio
Farallon Capital Management LLC San Francisco, CA

1.56M
Shares

$7.16 Million
0.0% of portfolio
Disciplined Growth Investors Inc Minneapolis, MN

1.11M
Shares

$5.12 Million
0.01% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.11M
Shares

$5.1 Million
0.0% of portfolio

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $247M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account